Julia Fuereder
Overview
Explore the profile of Julia Fuereder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urbas R, Mayr C, Klieser E, Fuereder J, Bach D, Stattner S, et al.
Int J Mol Sci
. 2016 Dec;
17(12).
PMID: 27941621
Extensive stromal interaction is one reason for the dismal outcome of biliary tract cancer (BTC) patients. Epithelial to mesenchymal transition (EMT) is involved in tumor invasion and metastasis and is...
2.
Kiesslich T, Mayr C, Wachter J, Bach D, Fuereder J, Wagner A, et al.
Mol Cell Biochem
. 2014 Jul;
396(1-2):257-68.
PMID: 25064451
Hedgehog (Hh) signalling contributes to carcinogenesis and represents a valid druggable target in human cancers, possibly also in biliary tract cancer (BTC). We analysed the expression of Hh components in...
3.
Bach D, Fuereder J, Karbiener M, Scheideler M, Ress A, Neureiter D, et al.
J Photochem Photobiol B
. 2013 Mar;
120:74-81.
PMID: 23466801
Photodynamic therapy (PDT) is a local tumour treatment accepted for a number of indications. PDT operates via the cellular stress response through the production of reactive oxygen species and subsequent...
4.
Wachter J, Neureiter D, Alinger B, Pichler M, Fuereder J, Oberdanner C, et al.
Int J Biol Sci
. 2012 Jan;
8(1):15-29.
PMID: 22211101
Background: The role of Wnt signalling in carcinogenesis suggests compounds targeting this pathway as potential anti-cancer drugs. Several studies report activation of Wnt signalling in biliary tract cancer (BTC) thus...